Heyman Richard A. bought ORIC
October 3, 2025 · Form 4 insider transaction
Heyman Richard A. bought 1,447 shares of ORIC Pharmaceuticals, Inc. at $3.75 per share, a transaction worth $5.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,447
Price
$3.75
Total value
$5.4K
InsiderHeyman Richard A.
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 3, 2025
Filing dateOctober 3, 2025
Shares owned after45,300
OwnershipDirect
10b5-1 planNo
AmendedNo